Thomas M Gress Selected Research

Trypsin

1/2008	Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
6/2006	A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas M Gress Research Topics

Disease

44	Neoplasms (Cancer) 02/2024 - 01/2002
41	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 08/2003
10	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021 - 01/2009
8	Chronic Pancreatitis 01/2014 - 03/2004
7	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2002
6	Adenocarcinoma 11/2023 - 07/2004
5	Carcinogenesis 06/2016 - 01/2002
5	Pancreatitis 01/2016 - 12/2006
4	Autoimmune Pancreatitis 01/2024 - 09/2013
4	Carcinoma (Carcinomatosis) 11/2023 - 03/2004
4	Primitive Neuroectodermal Tumors (PNET) 11/2021 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 03/2004
3	Neuroendocrine Carcinoma 02/2024 - 01/2017
2	Insulinoma 11/2023 - 10/2018
2	Fibrosis (Cirrhosis) 01/2014 - 09/2013
2	Obstructive Jaundice (Cholestatic Jaundice) 01/2014 - 09/2013
1	Neuroblastoma 03/2023
1	Tuberous Sclerosis (Bourneville's Disease) 01/2023
1	Esophageal Perforation 05/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Pain (Aches) 09/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2020
1	Squamous Cell Carcinoma of Head and Neck 02/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Hemorrhage 01/2020
1	Gastroesophageal Reflux (GERD) 01/2019
1	Dyspepsia (Indigestion) 01/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2003
7	Transcription Factors (Transcription Factor)IBA 02/2024 - 03/2010
6	Transforming Growth Factor beta (TGF-beta)IBA 08/2010 - 01/2002
5	Messenger RNA (mRNA)IBA 12/2017 - 03/2004
3	Immunoglobulin G (IgG)IBA 01/2024 - 09/2013
3	Dacarbazine (DIC)FDA LinkGeneric 11/2021 - 01/2017
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 01/2017
3	MicroRNAs (MicroRNA)IBA 12/2017 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2013
3	Peptide Hydrolases (Proteases)FDA Link 12/2013 - 01/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 01/2003
2	Chromogranin AIBA 11/2023 - 01/2017
2	Calcibiotic Root Canal SealerIBA 11/2023 - 03/2023
2	Interleukin-18 (Interleukin 18)IBA 01/2023 - 01/2023
2	AntigensIBA 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 07/2013
2	OvalbuminIBA 01/2023 - 01/2023
2	Phosphotransferases (Kinase)IBA 11/2020 - 02/2016
2	Hyaluronic Acid (Hyaluronan)IBA 10/2020 - 10/2012
2	Clodronic Acid (Clodronate)IBA 10/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 09/2017 - 12/2006
2	Streptozocin (Streptozotocin)FDA Link 01/2017 - 01/2017
2	CytokinesIBA 01/2017 - 12/2013
2	Alkylating AgentsIBA 01/2017 - 01/2017
2	CyclinsIBA 03/2016 - 06/2014
2	NFATC Transcription FactorsIBA 03/2016 - 08/2011
2	Gemcitabine FDA Link 01/2016 - 02/2013
2	Cyclin D1IBA 01/2016 - 12/2006
2	Rituximab (Mabthera)FDA Link 01/2014 - 09/2013
2	Azathioprine (Imuran)FDA LinkGeneric 01/2014 - 09/2013
2	Immunologic Factors (Immunomodulators)IBA 01/2014 - 09/2013
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2014 - 09/2013
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2014 - 09/2013
2	SteroidsIBA 01/2014 - 09/2013
2	Claudin-4IBA 07/2013 - 10/2003
2	ThymidineIBA 02/2012 - 08/2003
2	EnzymesIBA 03/2010 - 01/2008
2	TrypsinIBA 01/2008 - 06/2006
2	Sp1 Transcription FactorIBA 02/2007 - 12/2006
2	VimentinIBA 02/2007 - 08/2003
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2004 - 10/2003
2	AgarIBA 10/2003 - 08/2003
1	SynaptophysinIBA 11/2023
1	Adrenergic Agents (Adrenergic Drugs)IBA 03/2023
1	trans-sodium crocetinate (crocetin)IBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	Toll-Like Receptor 7IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	RamucirumabIBA 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2021
1	Volatile Fatty AcidsIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	ValeratesIBA 01/2021
1	ceralasertibIBA 11/2020
1	CollagenIBA 10/2020
1	PlatinumIBA 05/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	SmokeIBA 01/2020
1	Proton Pump InhibitorsIBA 01/2020
1	FructoseIBA 01/2019
1	Lactose FDA LinkGeneric 01/2019
1	HydrogenIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	DNA Primase (Primase)IBA 11/2018

Therapy/Procedure

15	Therapeutics 05/2022 - 05/2011
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2017
2	Immunotherapy 01/2021 - 10/2020
2	Radiotherapy 01/2016 - 01/2009
1	Decompression 09/2020
1	Adjuvant Chemotherapy 05/2020
1	Gastrostomy 02/2020
1	Enteral Nutrition (Feeding, Tube) 02/2020